HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

3rd Edition of International Conference on Probiotics and Prebiotics

March 27-29, 2025

March 27 -29, 2025 | Singapore
PROBIOTICS 2023

Impact of gut microbiome and intestinal parasite in immune-mediated bowel disease

Speaker at International Conference on Probiotics and Prebiotics 2023 - Manish Kumar Gautam
Assam down town University, India
Title : Impact of gut microbiome and intestinal parasite in immune-mediated bowel disease

Abstract:

Minor parasite invasion has decreased in developed nations over the past few years. Additionally, transmissible agents can defeat autoimmune conditions and hypersensitive reactions. Irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) are the two most common immune-mediated intestinal ailments, and a few studies have shown that a variety of protozoa and helminths are linked to these conditions. IBD, or inflammatory bowel disease, refers to inflammatory disorders of the stomach, small intestine, and colon, including ulcerative colitis and Crohn's disease. IBD's specific cause is still unknown, however, it may be related to variations in the intestine's microflora that lead to an excessive inflammatory response to commensal microbiota. Irritable bowel syndrome is essentially a long-lasting, persistent gastrointestinal illness and symptoms typically include swelling, cramps or severe pain, diarrhoea, and constipation. The immune systems of infected hosts can be affected by various intestinal parasites, and in some situations, they can change or vary the host's immunological responses, especially in autoimmune diseases like celiac disease and inflammatory bowel disease (IBD). We found that intestinal parasites and gut microbiome have a relation for causing IBD and by maintaining the gut microbiome the disease burden may be reduced. 

Biography:

Manish Kumar Gautam is an Associate Professor in Faculty of Pharmaceutical Sciences, Assam down town University, Guwahati-781026, Assam, India. He has completed his Ph.D. in Pharmacology from, Banaras Hindu University (BHU), Varanasi, India. He has handled and co-ordinate many extramural and intramural research projects. He has acquired more than 11 years of research experience. He has been awarded two International travel grants from the Indian Council of Medical Research (ICMR) and SERB (DST) respectively for research paper presentations in London, UK, and Malaysia. He has also been awarded “Certificate of Excellence” by EET-CRS 2nd Science and Technology award 2014. He has undergone various training programs and workshops in reputed organizations and presented more than 18 full papers/Abstracts in various national and international conferences. He contributed as a Technical Support Expert for the Development of Guidelines and consultative process “General Guidelines for Safety/Toxicity Evaluation of Ayurvedic Formulations” published by Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India, New Delhi, India. He also contributed to 5 books and 6 book chapters and has 46 Research papers in various national and international journals. His area of research is the safety and efficacy of drugs in various animal models.

Watsapp